D59 |
|
Acquired hemolytic anemia  |
| |
D59.0 |
 |
Drug-induced autoimmune hemolytic anemia |
| |
UseAdditionalCode |
code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
|
|
|
| |
D59.1 |
 |
Other autoimmune hemolytic anemias |
| |
Excludes2 |
Evans syndrome (D69.41) hemolytic disease of newborn (P55.-) paroxysmal cold hemoglobinuria (D59.6)
|
|
| |
D59.10 |
|
Autoimmune hemolytic anemia, unspecified |
| | |
D59.11 |
 |
Warm autoimmune hemolytic anemia |
| |
Warm type (primary) (secondary) (symptomatic) autoimmune hemolytic anemia | Warm type autoimmune hemolytic disease |
|
| | |
D59.12 |
 |
Cold autoimmune hemolytic anemia |
| |
Chronic cold hemagglutinin disease | Cold agglutinin disease | Cold agglutinin hemoglobinuria | Cold type (primary) (secondary) (symptomatic) autoimmune hemolytic anemia | Cold type autoimmune hemolytic disease |
|
| | |
D59.13 |
 |
Mixed type autoimmune hemolytic anemia |
| |
Mixed type autoimmune hemolytic disease | Mixed type, cold and warm, (primary) (secondary) (symptomatic) autoimmune hemolytic anemia |
|
| | |
D59.19 |
|
Other autoimmune hemolytic anemia |
| |
| |
D59.2 |
 |
Drug-induced nonautoimmune hemolytic anemia |
| |
Drug-induced enzyme deficiency anemia |
UseAdditionalCode |
code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
|
|
|
| |
D59.3 |
 |
Hemolytic-uremic syndrome |
| |
CodeAlso |
, if applicable, any associated: acute kidney failure (N17.-) chronic kidney disease (N18.-)
|
|
| |
D59.30 |
 |
Hemolytic-uremic syndrome, unspecified |
| |
Hemolytic-uremic syndrome NOS |
|
| | |
D59.31 |
 |
Infection-associated hemolytic-uremic syndrome |
| |
Shiga toxin-producing E. coli [STEC] related hemolytic uremic syndrome | Typical hemolytic uremic syndrome |
UseAdditionalCode |
code to identify associated infection, such as : E. coli infection (B96.2-) Human immunodeficiency virus [HIV] disease (B20) Pneumococcal meningitis (G00.1) Pneumococcal pneumonia (J13) Sepsis due to Streptococcus pneumoniae (A40.3) Shigella dysenteriae (A03.9) Streptococcus pneumoniae as the cause of diseases classified elsewhere (B95.3)
|
|
| | |
D59.32 |
 |
Hereditary hemolytic-uremic syndrome |
| |
Atypical hemolytic uremic syndrome with an identified genetic cause |
CodeAlso |
, if applicable: defects in the complement system (D84.1) methylmalonic acidemia (E71.120)
|
|
| | |
D59.39 |
 |
Other hemolytic-uremic syndrome |
| |
Atypical (nongenetic) hemolytic uremic syndrome | Secondary hemolytic-uremic syndrome |
CodeFirst |
, if applicable, any associated: COVID-19 (U07.1) complications of kidney transplant (T86.1-) complications of heart transplant (T86.2-) complications of liver transplant (T86.4-)
|
CodeAlso |
, if applicable, any associated condition, such as: hypertensive emergency (I16.1) malignant neoplasm (C00-C96) systemic lupus erythematosus (M32.-)
|
UseAdditionalCode |
code, if applicable, for adverse effect to identify drug (T36-T50 with fifth or sixth character 5)
|
|
| |
| |
D59.4 |
 |
Other nonautoimmune hemolytic anemias |
| |
Mechanical hemolytic anemia | Microangiopathic hemolytic anemia | Toxic hemolytic anemia |
|
|
| |
D59.5 |
 |
Paroxysmal nocturnal hemoglobinuria [Marchiafava-Micheli] |
| |
Excludes1 |
hemoglobinuria NOS (R82.3)
|
|
|
| |
D59.6 |
 |
Hemoglobinuria due to hemolysis from other external causes |
| |
Hemoglobinuria from exertion | March hemoglobinuria | Paroxysmal cold hemoglobinuria |
UseAdditionalCode |
code (Chapter 20) to identify external cause
|
Excludes1 |
hemoglobinuria NOS (R82.3)
|
|
|
| |
D59.8 |
|
Other acquired hemolytic anemias |
|
| |
D59.9 |
 |
Acquired hemolytic anemia, unspecified |
| |
Idiopathic hemolytic anemia, chronic |
|
|